Business Continuity During the COVID-19 Pandemic Era: Surviving and Improving the Quality Process Management System
Creators
- 1. Sector of Industrial Management and Operations Research, School of Mechanical Engineering, National Technical University of Athens
- 2. Postgraduate Program on Quality Management and Technology, Hellenic Open University
Description
Publication on: WSEAS Transactions on Environment and Development, vol. 18, 2022, pp. 617-641
Abstract: Worldwide health and the global economy have been heavily damaged by the COVID-19 pandemic,with business continuity being the primary issue of every company operating in the health industry. A criticalinstrument for enterprises' survival is the establishment of a business continuity management system that enablesthem to manage risks, discover opportunities created by the pandemic, and secure their continuity. The purposeof this paper is to examine how a pharmaceutical firm may ensure business continuity by adopting ISO22301:2019 in parallel with the existing ISO 9001:2015 quality standard, as well as the similarities anddifferences between the two management standards. According to the results, the pharmaceutical company,whose case was studied, managed to create an effective action plan in order to mitigate at an acceptable level theidentified risks, to maintain its business continuity and to ensure the quality of the product and the health of thepatients and its employees.
Files
b245115-016(2022).pdf
Files
(1.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:8c2fced58c000bd2b242e40f242c5568
|
1.5 MB | Preview Download |